You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 292 No. 17, November 3, 2004 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Academic Innovations
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on ISI (1)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Genetic Counseling/ Testing/ Therapy
 •Informatics/ Internet in Medicine
 •Informatics, Other
 •Alert me on articles by topic

Tool Helps Cancer Scientists Mine Genes

Tracy Hampton, PhD

JAMA. 2004;292:2073.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

When DNA microarrays first came on the research scene some 10 years ago, researchers predicted that the devices, which can screen for the activity of thousands of genes simultaneously, would be essential to understanding the roles played by specific genes in cancer and other diseases. Today, data from thousands of DNA microarray studies are available for scientists to peruse.

But researchers trying to mine this mother lode of information can have a difficult time sifting through the mass of published microarray data to find meaningful nuggets of information. Some help is on the way, however—at least for scientists interested in cancer microarrays—in the form of a new tool called Oncomine (http://www.oncomine.org).


Arul Chinnaiyan, MD, PhD (Photo credit: Martin Vloet, University of Michigan Photo Services)

Oncomine, the brainchild of Arul Chinnaiyan, MD, PhD, of the University of Michigan in Ann Arbor, is a proprietary compilation of . . . [Full Text of this Article]



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The La Autoantigen Is a Malignancy-Associated Cell Death Target That Is Induced by DNA-Damaging Drugs
Al-Ejeh et al.
Clin. Cancer Res. 2007;13:5509s-5518s.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.